Skip to main content
Equibles

BARCLAYS PLC

Position in CRDF — Cardiff Oncology, Inc.

CIK 312069 LONDON, X0
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,028
-$11,870 QoQ
Shares Held
5,407
-53.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 104 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. CRDF ranks #331 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in CRDF

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,028 5,407
2026-03-31 $18,898 11,666
2025-12-31 $277,805 98,863
2025-09-30 $179,712 87,239
2025-06-30 $338,738 107,536
2025-03-31 $193,916 61,757
2024-12-31 $271,666 62,596
2024-09-30 $141,747 53,089
2024-06-30 $30,074 13,547
2022-06-30 $8 4
2022-03-31 $15,346 6,188